A guide to cost-effective management of leg ulcers

2021 ◽  
Vol 27 (5) ◽  
pp. 136-144
Author(s):  
Matthew Taylor ◽  
Leanne Atkin

Chronic wounds have a substantial economic impact on the NHS, with leg ulcers alone costing almost £4.6 billion per year. Approximately 2% of the adult population is affected by lower limb ulceration, and this is rising as a result of demographics, including longer life expectancy and the increasing prevalence of obesity and diabetes. Even after healing, the recurrence rate of leg ulcers is high, meaning that the cost and health impact is a long-term problem. There appears to be a large variation in treatment methods, possibly as a result of a lack of evidence-based practices. The variation in practice means that, in many areas, healing times are far from optimal, leading to increased costs and health burden for the patient. This article outlines a number of previously published recommendations, including the leg ulcer treatment pathway. The article also provides an overview of the considerations when undertaking an economic evaluation of pathways, and provides recommendations about the type of data that should be routinely collected in clinical trials.

2009 ◽  
Vol 29 (6) ◽  
pp. 678-689 ◽  
Author(s):  
Matt D. Stevenson ◽  
Jeremy E. Oakley ◽  
Myfawny Lloyd Jones ◽  
Alan Brennan ◽  
Juliet E. Compston ◽  
...  

Purpose. Five years of bisphosphonate treatment have proven efficacy in reducing fractures. Concerns exist that long-term bisphosphonate treatment may actually result in an increased number of fractures. This study evaluates, in the context of England and Wales, whether it is cost-effective to conduct a randomized controlled trial (RCT) and what sample size may be optimal to estimate the efficacy of bisphosphonates in fracture prevention beyond 5 years. Method. An osteoporosis model was constructed to evaluate the cost-effectiveness of extending bisphosphonate treatment from 5 years to 10 years. Two scenarios were run. The 1st uses long-term efficacy data from published literature, and the 2nd uses distributions elicited from clinical experts. Results of a proposed RCT were simulated. The expected value of sample information technique was applied to calculate the expected net benefit of sampling from conducting such an RCT at varying levels of participants per arm and to compare this with proposed trial costs. Results. Without further information, the better duration of bisphosphonate treatment was estimated to be 5 years using the published data but 10 years using the elicited expert opinions, although in both cases uncertainty was substantial. The net benefit of sampling was consistently high when between 2000 and 5000 participants per arm were recruited. Conclusions. An RCT to evaluate the long-term efficacy of bisphosphonates in fracture prevention appears to be cost-effective for informing decision making in England and Wales.


2019 ◽  
Vol 55 (5) ◽  
pp. 292-305
Author(s):  
Shazia Jamshed ◽  
Akshaya Srikanth Bhagavathula ◽  
Sheikh Muhammad Zeeshan Qadar ◽  
Umaira Alauddin ◽  
Sana Shamim ◽  
...  

Background: Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder that results from regurgitation of acid from the stomach into the esophagus. Treatment available for GERD includes lifestyle changes, antacids, histamine-2 receptor antagonists (H2RAs), proton pump inhibitors (PPIs), and anti-reflux surgery. Aim: The aim of this review is to assess the cost-effectiveness of the use of PPIs in the long-term management of patients with GERD. Method: We searched in PubMed to identify related original articles with close consideration based on inclusion and exclusion criteria to choose the best studies for this narrative review. The first section compares the cost-effectiveness of PPIs with H2RAs in long-term heartburn management. The other sections shall only discuss the cost-effectiveness of PPIs in 5 different strategies, namely, continuous (step-up, step-down, and maintenance), on-demand, and intermittent therapies. Results: Of 55 articles published, 10 studies published from 2000 to 2015 were included. Overall, PPIs are more effective in relieving heartburn in comparison with ranitidine. The use of PPIs in managing heartburn in long-term consumption of nonsteroidal anti-inflammatory drug (NSAID) has higher cost compared with H2RA. However, if the decision-maker is willing to pay more than US$174 788.60 per extra quality-adjusted life year (QALY), then the optimal strategy is traditional NSAID (tNSAID) and PPIs. The probability of being cost-effective was also highest for NSAID and PPI co-therapy users. On-demand PPI treatment strategy showed dominant with an incremental cost-effectiveness ratio of US$2197 per QALY gained and was most effective and cost saving compared with all the other treatments. The average cost-effectiveness ratio was lower for rabeprazole therapy than for ranitidine therapy. Conclusion: Our review revealed that long-term treatment with PPIs is effective but costly. To achieve long-term cost-effective approach, we recommend on-demand approach to treat heartburn symptoms, but if the symptoms persist, treatment with continuous step-down therapy should be applied.


Energies ◽  
2020 ◽  
Vol 13 (10) ◽  
pp. 2507
Author(s):  
Sou-Sen Leu ◽  
Tao-Ming Ying

After the long-term operation of reservoir facilities, they will become nonoperational due to the material deterioration and the performance degradation. One of crucial decisions is to determine the maintenance or replacement of the facilities in a cost-effective manner. Conventional replacement models seldom consider the maintenance effect. The facilities after maintenance are generally not as good as new, but are relatively restored. The target of this study is to establish a replacement decision model of the reservoir facilities under imperfect maintenance. By combining the theories of reliability analysis, imperfect maintenance, and engineering economics, the best timing of replacement that achieves cost-effectiveness is analyzed and proposed. Lastly, based on the design of experiments (DOE) and simulation, the regression curve chart for the economical replacement decision is established. Once the failure rate, the age of recovery after maintenance, and the ratio of maintenance cost to replacement cost are estimated based on historical data, the cost-effective replacement time of hydraulic machinery facilities will be efficiently determined.


Obesity Facts ◽  
2020 ◽  
Vol 13 (5) ◽  
pp. 487-498
Author(s):  
Ewa Bandurska ◽  
Michał Brzeziński ◽  
Paulina Metelska ◽  
Marzena Zarzeczna-Baran

<b><i>Background:</i></b> Obesity and overweight, including childhood obesity and overweight, pose a public health challenge worldwide. According to the available research findings, long-term interventions focusing on dietary behavior, physical activity, and psychological support are the most effective in reducing obesity in children aged 6–18 years. There are limited studies showing the financial effectiveness of such interventions. <b><i>Objective:</i></b> The objective of the present study was to evaluate cost-effectiveness of the 6-10-14 for Health weight management program using pharmacoeconomic indicators, i.e., cost-effectiveness analysis using the incremental cost-effectiveness ratio. <b><i>Methods:</i></b> We used anthropometric data of 3,081 children included in a 1-year-long intervention with a full financial cost assessment. <b><i>Results:</i></b> The cost of removing a child from the overweight group (BMI &#x3e;85th percentile) was PLN 27,758 (EUR 6,463), and the cost of removing a child from the obese group (BMI &#x3e;95th percentile) was slightly lower, i.e., PLN 23,601 (EUR 5,495). Given the obesity-related medical costs calculated in the life-long perspective, these results can be considered encouraging. At the same time, when comparing the total costs per participant with the costs of other interventions, it can be noted that they are similar to the costs of school programs containing more than 1 type of intervention. <b><i>Conclusions:</i></b> The 6-10-14 for Health program can be considered cost-effective. As a result of committing financial resources in the approximate amount of EUR 1,790 per child, around half of the children participating in the program have improved their weight indicators.


2020 ◽  
Vol 8 (9) ◽  
pp. 3010-3016 ◽  
Author(s):  
Chunhua Su ◽  
Meijia Qiu ◽  
Yipeng An ◽  
Siyuan Sun ◽  
Chuanxi Zhao ◽  
...  

Long-term stable, fast switching α-Ni(OH)2 electrodes for electrochromic energy storage application has been fabricated by one-step preheating treatment. The cost-effective fabrication is expected to expand to other metal hydroxide materials.


Author(s):  
Marijke Keus Van De Poll ◽  
Gunnar Bergström ◽  
Irene Jensen ◽  
Lotta Nybergh ◽  
Lydia Kwak ◽  
...  

The cost-benefit and cost-effectiveness of a work-directed intervention implemented by the occupational health service (OHS) for employees with common mental disorders (CMD) or stress related problems at work were investigated. The economic evaluation was conducted in a two-armed clustered RCT. Employees received either a problem-solving based intervention (PSI; n = 41) or care as usual (CAU; n = 59). Both were work-directed interventions. Data regarding sickness absence and production loss at work was gathered during a one-year follow-up. Bootstrap techniques were used to conduct a Cost-Benefit Analysis (CBA) and a Cost-Effectiveness Analysis (CEA) from both an employer and societal perspective. Intervention costs were lower for PSI than CAU. Costs for long-term sickness absence were higher for CAU, whereas costs for short-term sickness absence and production loss at work were higher for PSI. Mainly due to these costs, PSI was not cost-effective from the employer’s perspective. However, PSI was cost-beneficial from a societal perspective. CEA showed that a one-day reduction of long-term sickness absence costed on average €101 for PSI, a cost that primarily was borne by the employer. PSI reduced the socio-economic burden compared to CAU and could be recommended to policy makers. However, reduced long-term sickness absence, i.e., increased work attendance, was accompanied by employees perceiving higher levels of production loss at work and thus increased the cost for employers. This partly explains why an effective intervention was not cost-effective from the employer’s perspective. Hence, additional adjustments and/or support at the workplace might be needed for reducing the loss of production at work.


Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 3128-3128
Author(s):  
Cecilia C. Yeung ◽  
Maggie A. Gama ◽  
Rodriguez Rafael ◽  
Edward C. Larkin ◽  
Kim Janatpour

Abstract Intro: Tonsillectomy is a common surgery for both adults and children. In children (under 18 years) the most common diagnosis is follicular hyperplasia. In adults (18 years and older) the most common neoplastic diagnosis is squamous cell carcinoma. Although a common fear of lymphoma involving the tonsils persist, the literature indicates non-Hodgkin lymphoma as the least common diagnosis among tonsillectomy specimens. The purpose of this study was to provide indications and guidelines to delineate a cost effective approach for selection of tonsils for lymphoma workup. At UC Davis Medical Center, if lymphoma is considered in the differential, the tonsil is processed through a lymphoma workup protocol; touch preps, flow cytometry, cytogenetics, electron microscopy, B5-fixed, and formalin-fixed tissue in paraffin. Tissue is frozen in liquid nitrogen and stored for possible future studies. This approach diminishes the possibility of a missed lymphoma diagnosis, however it is costly and labor intensive. The initial phase of our investigation involved the identification of worrisome clinical findings for comparison with our patient population. Next, we address the incidence of tonsillar lymphoma in children versus adults in our hospital because the two populations historically exhibit drastically different diagnoses. In the final phase of our investigation we address the cost effectiveness of our approach. Method: To define what clinical findings are worrisome, we performed a literature search of “tonsillectomy and lymphoma” on pubmed and revealed 60 articles dating back to 1980 with 22 articles selected for review. Next, we reviewed over 900 tonsillar specimens collected over five years at the Medical Center. This data was stratified with respect to age, diagnoses, and whether a lymphoma workup was performed. Data: Prominent worrisome clinical findings included: unilateral enlargement, rapidly growing tonsillar mass, and grossly asymmetric tonsils. The results of our specimen (UC Davis) review is included in the chart below. In 5 years lymphoma workups were performed in19 children and 42 adults. The cost of each workup was $4063.00 and Medicare reimburses $1180. Conclusion: The incidence of lymphoma in our pediatric population is 0 and in our adult population is less than 1%. The cost per lymphoma diagnosis in our pediatric population exceeds $77,197.00. In contrast, the cost per lymphoma diagnosis in our adult population is $21,330.00. This data in conjunction with our literature search leads us to recommend selecting specimens for lymphoma work up in both adults and pediatric patients with the clinical findings of unilateral growth, rapidly enlarging tonsillar mass, and grossly asymmetric tonsils as a criteria. Special consideration in the pediatric population should also include strong clinical suspicion for lymphoma prior to ordering a lymphoma workup due to an extremely low incidence. Tonsillar diagnoses in Children versus Adults Benign Lymphoma Other Neoplasm Children (n=372) 372 0 0 Adults (n=654) 572 8 82 Total (n=1034) 944 (91%) 8 (<1%) 82 (8%) Benign diagnoses include: follicular hyperplasia, benign mucosa and tonsillar tissue, amyloidosis, acute and chronic tonsillitis.Lymphoma diagnoses include: large B-cell , follicle center cell , and lymphoblastic lymphoma. Other Neoplasm diagnoses include: squamous cell and basal cell and metastatic adenocarcinoma, malignant spindle cell sarcoma.


2002 ◽  
Vol 22 (1_suppl) ◽  
pp. 45-57 ◽  
Author(s):  
Patricia Vold Pepper ◽  
Douglas K. Owens

Objectives Routine vaccination for Streptococcus pneumoniae has been recommended as a cost-effective measure for elderly and immunocompromised patients, yet no analysis has been performed for healthy younger adults in America. The authors evaluated the cost-effectiveness of the pneumococcal vaccine and determined the net health benefits conferred for the healthy young adult population. Methods The authors developed a decision model to compare the health and economic outcomes of vaccinate versus do not vaccinate for S. pneumoniae. Results Vaccinating patients for S. pneumoniae generates benefits that are dependent on incidence rates and the efficacy of the vaccine. In the 22-year-old patient with a pneumonia incidence of 0.3/1000, the vaccine would need to be >71 percent effective for the vaccination strategy to cost less than $50,000/QALY gained. At an incidence of 0.4/1000, the threshold efficacy is 53 percent, whereas at 0.5/1000 it is 43 percent. In the 35-year-old patient where the incidence of pneumococcal pneumonia is higher (0.85/1000), the vaccine would be cost-effective with an efficacy as low as 30 percent. Conclusions Use of the S. pneumoniae vaccine in young adults would provide modest reductions in pneumonia-associated morbidity and mortality. Vaccination of young adults is moderately expensive unless vaccine efficacy is above 50% to 60%. In 35-year-old adults, use of the vaccine is cost-effective even with moderate efficacy.


2021 ◽  
Author(s):  
Melike Yildirim ◽  
Bradley Gaynes ◽  
Pinar Keskinocak ◽  
Brian Pence ◽  
Julie L Swann

Objective. Screening has an essential role in preventive medicine. Ideally, screening tools detect patients early enough to manage the disease and reduce symptoms. We aimed to determine the cost-effectiveness of routine screening schedules. Methods. We used a discrete-time nonstationary Markov model to simulate the progression of depression. We adopted annual transition probabilities, which were dependent on patient histories, such as the number of previous episodes, treatment status, and time spent without treatment state based on the available data. We used Monte Carlo techniques to simulate the stochastic model for 20 years or during the lifetime of individuals. Baseline and screening scenario models with screening frequencies of annual, 2-year, and 5-year were compared based on incremental cost-effectiveness ratios (ICER). Results. In the general population, all screening strategies were cost-effective compared to the baseline. However, male and female populations differed based on cost over quality-adjusted life years (QALY). Females had lower ICERs, and annual screening had the highest ICER for females, with 11,134 $/QALY gained. In contrast, males had around three times higher ICER, with annual screening costs of 34,065$/QALY gained. Conclusions. Considering the high lifetime prevalence and recurrence rates of depression, detection and prevention efforts can be one critical cornerstone to support required care. Our analysis combined the expected benefits and costs of screening and assessed the effectiveness of screening scenarios. We conclude that routine screening is cost-effective for all age groups of females and young, middle-aged males. Male population results are sensitive to the higher costs of screening.


Sign in / Sign up

Export Citation Format

Share Document